Title:
FORMULATION COMPRISING BENZOTHIAZOLONE COMPOUND
Document Type and Number:
Japanese Patent JP2018035186
Kind Code:
A
Abstract:
PROBLEM TO BE SOLVED: To provide a pharmaceutical composition in a novel physical form which may improve efficiency, bioavailability, stability and/or acceptance by the patient, of (R)-7-(2-(1-(4-butoxyphenyl)-2-methylpropan-2-ylamino)-1-hydroxyethyl)-5-hydroxybenzo[d]thiazol-2(3H)-one.SOLUTION: A solid oral dosage form comprises an acetate comprising 0.01 to 15% (w/w) of the compound, and one or more pharmaceutically acceptable additives selected from filler, lubricant, glidant, disintegrant and binder.SELECTED DRAWING: None
Inventors:
MILOUD ACHOUR
ROBIN ALEC FAIRHURST
ARNAUD GRANDEURY
HATAYAMA SHINJI
MAGDALENA KOZICZAK-HOLBRO
NICOLA TUFILLI
THOMAS ULLRICH
ROBIN ALEC FAIRHURST
ARNAUD GRANDEURY
HATAYAMA SHINJI
MAGDALENA KOZICZAK-HOLBRO
NICOLA TUFILLI
THOMAS ULLRICH
Application Number:
JP2017199975A
Publication Date:
March 08, 2018
Filing Date:
October 16, 2017
Export Citation:
Assignee:
NOVARTIS AG
International Classes:
A61K31/428; A61K9/20; A61K9/48; A61P21/00; A61P21/04; A61P35/00
Domestic Patent References:
| JP6230626B2 | 2017-11-15 | |||
| JP2008520618A | 2008-06-19 |
Attorney, Agent or Firm:
Hiroshi Kobayashi
Norio Omori
Kyoko Tamura
Yasuhito Suzuki
Norio Omori
Kyoko Tamura
Yasuhito Suzuki